ABPWW
ABPWW is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 29.7 (oversold), with 0/3 trend checks passing.
ABPWW with MA50 and MA200
Key levels & signals
ABPWW currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.00, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 81.5% and below the 200-day moving average by 91.7%.
ABPWW currently has an RSI reading of 29.7, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.
For traders reviewing ABPWW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Abpro Holdings Inc
Abpro Holdings Inc. is a biotechnology firm dedicated to creating sophisticated antibody-based treatments for individuals grappling with immuno-oncology, ophthalmology, and autoimmune disorders. The company's innovative DiversImmune platform is specifically engineered to resolve a key hurdle currently facing the antibody therapeutics sector. Among its leading experimental therapies are ABP-100, designed to combat breast, gastric, and colorectal cancers, and ABP-201, aimed at treating vascular conditions affecting the eye. Abpro Holdings also benefits from important collaborations with Abpro Bio Co. Ltd and NJCTTQ. Established in 2004, the company, originally known as Abpro Corporation, officially adopted its current name, Abpro Holdings, Inc., in November 2024. Its corporate headquarters are situated in Woburn, Massachusetts.
Learn the indicators behind this page
More stock opportunities
Common questions about ABPWW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.